CIK 0001601485
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113430072
- Phone
- +1 857-209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- 4 Other disposition 10% owner disposed of 913,659 shares (other)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Neylan John F. sold 381 shares at $9.03 ($3,440)
- 4 Open-market sale Rhodes Jennifer J sold 445 shares at $10.68 ($4,753)
- 4 Open-market sale Rhodes Jennifer J sold 432 shares at $10.94 ($4,726)
- 4 Open-market sale Neylan John F. sold 365 shares at $10.98 ($4,008)
- 4/A Insider Changes in Ownership
- 4 Open-market sale Rhodes Jennifer J sold 431 shares at $11.01 ($4,745)
- 4 Open-market sale Neylan John F. sold 366 shares at $13.20 ($4,831)
- 4 Open-market sale Rhodes Jennifer J sold 427 shares at $13.27 ($5,666)
- 4 Open-market sale Neylan John F. sold 363 shares at $13.91 ($5,049)
- 4 Open-market sale Rhodes Jennifer J sold 440 shares at $13.92 ($6,125)
- 4 Open-market sale Neylan John F. sold 381 shares at $13.55 ($5,163)
- 4 Open-market sale Rhodes Jennifer J sold 399 shares at $15.01 ($5,989)
- 4 Open-market sale Neylan John F. sold 442 shares at $19.13 ($8,455)
- 4 Open-market sale Rhodes Jennifer J sold 499 shares at $20.45 ($10,205)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 7 · 140 filings